Dr Gunashree Nagaraju1, Dr Annie Reynolds 1HBDHB, HASTINGS, NEW ZEALAND Background Newer cancer treatments which include targeted therapy and immunotherapy agents are being increasingly recognised to cause kidney injury. Kadcyla (Trastuzumab emtansine) is a HER2-targeted antibody-drug conjugate. In current practise...
- 28 July 2022
Mr Michael Ooi1, Dr Prianka Puri2 1Princess Alexandra Hospital, Brisbane, Australia, 2Royal Brisbane and Women’s Hospital, Brisbane, Australia Background: Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis is rare, but associated with significant mortality and morbidity, with 10% of patients requiring chronic...
- 28 July 2022
Mr. NABEEL CHERIAN JOSH1,2,3, Dr. RAJNEESH KAUR1, Dr. DAVID TUNNICLIFFE2,3 1University of Sydney School of Medicine, Camperdown, Australia, 2Center for Kidney Research, The Children’s Hospital at Westmead, Westmead, Australia, 3Sydney School Public Health, University of Sydney, Camperdown, Australia Aim To...
- 27 July 2022
Dr Alastair Richards1, Dr JANAK DE ZOYSA1,2 1WAITEMATA DISTRICT HEALTH BOARD, AUCKLAND, NEW ZEALAND, 2DEPARTMENT OF MEDICINE, UNIVERSITY OF AUCKLAND, AUCKLAND, NEW ZEALAND Aim: To improve the understanding of the incidence, clinical features, therapies, and outcomes for New Zealand (NZ)...
- 27 July 2022
Makram Bou Ghannam1,3, Ken Chau1, Thin Han1,3, Bahram Forouzesh2,3, Zaw Thet1,3,4 1Department of Nephrology, Central Queensland Hospital and Health Service, Rockhampton, Australia, 2Cancer Care Unit, Central Queensland Hospital and Health Service, Rockhampton, Australia, 3Faculty of Medicine, University of Queensland ,...
- 27 July 2022
Dr CHATHRI RATNAYAKE1, Dr THEODORE CROMBIE1, Dr MARGARET FRAENKEL1, Proferssor LAWRENCE P. MCMAHON1,2, Dr LIMY WONG1,2 1Department of Renal Medicine, Eastern Health, , Australia, 2Department of Renal Medicine, Monash University Eastern Health Clinical School, , Australia Background Double-seropositive vasculitis is...
- 27 July 2022
Dr Vishwas Raghunath1, Dr Kevin YC Su1, Dr Faisal Ameer1, A/Prof Sree Krishna Venuthurupalli1 1West Moreton Hospital & Health Service, Queensland Health, Ipswich , Australia Background: The occurrence of ANCA-associated vasculitis (AAV) in patients with known systemic sclerosis has only...
- 27 July 2022
Dr JOCELYN SHAN1,2, Dr ZAKARIYA KANAAN2, A/Prof MUHAMMAD M JAVAID1,3,4 1South West Healthcare, Warrnambool, Australia, 2St Vincent’s Hospital, Melbourne, Australia, 3Monash University, , Australia, 4Deakin University, , Australia Background Immunoglobulin A Nephropathy (IgAN) is generally a slowly progressive disease, with...
- 27 July 2022
Dr LORNA RADFORD1, Dr PRIANKA PURI1 1Kidney Health Service, Royal Brisbane and Women’s Hospital, Metro North Hospital and Health Service, Brisbane, Australia Background Primary Membranous nephropathy (pMN) is one of the most common causes of nephrotic syndrome in adults. The...
- 27 July 2022
MAYY HAMDE1, AKSHAY ATHAVALE1,2, CELINE FOOTE1,2 1Department of Renal Medicine, Concord Repatriation and General Hospital, Concord, Australia, 2Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Concord, Australia Background IgA nephropathy with minimal change disease is a rare...
- 27 July 2022